SPECGX LLC FDA Approval ANDA 207000

ANDA 207000

SPECGX LLC

FDA Drug Application

Application #207000

Application Sponsors

ANDA 207000SPECGX LLC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;SUBLINGUALEQ 2MG BASE;EQ 0.5MG BASE0BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
002TABLET;SUBLINGUALEQ 8MG BASE;EQ 2MG BASE0BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-12-13STANDARD
LABELING; LabelingSUPPL2AP2019-09-23STANDARD
LABELING; LabelingSUPPL4AP2019-10-08STANDARD
LABELING; LabelingSUPPL7AP2021-02-16STANDARD
LABELING; LabelingSUPPL9AP2021-03-04STANDARD
LABELING; LabelingSUPPL16AP2022-06-14STANDARD
LABELING; LabelingSUPPL21AP2022-06-17STANDARD
REMS; REMSSUPPL22AP2022-05-03
LABELING; LabelingSUPPL24AP2022-06-17STANDARD
REMS; REMSSUPPL27AP2022-12-16

Submissions Property Types

ORIG1Null15
SUPPL2Null15
SUPPL4Null15
SUPPL7Null7
SUPPL9Null7
SUPPL16Null7
SUPPL21Null7
SUPPL22Null31
SUPPL24Null7
SUPPL27Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

SPECGX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207000
            [companyName] => SPECGX LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE","activeIngredients":"BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","strength":"EQ 2MG BASE;EQ 0.5MG BASE","dosageForm":"TABLET;SUBLINGUAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE","activeIngredients":"BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","strength":"EQ 8MG BASE;EQ 2MG BASE","dosageForm":"TABLET;SUBLINGUAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/13\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"10\/08\/2019","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert, Labeling-Medication Guide","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"09\/23\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"10\/31\/2018","submission":"SUPPL-1","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-10-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.